Foresite Capital

Venture Capital Active Los Angeles, United States Est. 2010
LinkedIn
Last updated 2026-06-18
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$111.0M
total disclosed, rounds participated
Stages
—

About

Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 12/31/23). The firm aims to address areas of great unmet need by funding promising healthcare and life sciences businesses at all stages of their life cycles. Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare, including 10x Genomics, Relay Therapeutics, Element Biosciences, Inscripta, as well as companies developing next generation therapeutics. Founded in 2011, Foresite Capital is based in San Francisco.

Portfolio · 1

ImmPACT Bio
CAR-T Cell Therapies for Treating Cancer
1 round $111.0M committed Latest: 2022-01

Investment activity

1 portfolio exit on record.

Portfolio by sector

Health Tech & Life Sciences1

Funds · 1

  • Life Sciences — $900M Jun 2024

Q&A

What is Foresite Capital's primary investment focus?
Foresite Capital is a multi-stage healthcare and life sciences investment firm. The firm aims to address areas of unmet need by funding promising healthcare and life sciences businesses at all stages.
What is the total amount of assets under management for Foresite Capital?
As of December 31, 2023, Foresite Capital has approximately $3.5 billion in assets under management.
When was Foresite Capital founded?
Foresite Capital was founded in 2011.
Has Foresite Capital recently raised a new fund?
Yes, Foresite Capital closed its Life Sciences fund in June 2024, raising $900 million.
Can you name a notable portfolio company of Foresite Capital?
ImmPACT Bio is a notable portfolio company of Foresite Capital, which focuses on CAR-T Cell Therapies for Treating Cancer.
Has Foresite Capital had any recent exits?
Yes, ImmPACT Bio, a portfolio company of Foresite Capital, was acquired by Lyell Immunopharma in October 2024.
What is Foresite Capital's investment strategy regarding data science?
Foresite Capital uses a data science-driven approach to invest in companies that leverage biology and big data to transform healthcare.
In which sector does Foresite Capital primarily invest?
Foresite Capital primarily invests in the Health Tech & Life Sciences sector, with all its recorded investment rounds and portfolio companies falling within this sector.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)